| Literature DB >> 12914552 |
Abstract
Noninferiority trials comparing new treatment with an active standard control are becoming increasingly common. This article discusses relevant issues regarding their need, design, analysis and interpretation: the appropriate choice of control group, types of noninferiority trial, ethical considerations, sample size determination and potential pitfalls to consider.Mesh:
Substances:
Year: 2003 PMID: 12914552 DOI: 10.1046/j.1472-8206.2003.00162.x
Source DB: PubMed Journal: Fundam Clin Pharmacol ISSN: 0767-3981 Impact factor: 2.748